Company Overview
About Endeavor Biomedicines
Endeavor Biomedicines is a clinical-stage biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, that is developing precision small-molecule medicines targeting the molecular drivers of fibrotic diseases and cancer. The company's scientific focus is on identifying and inhibiting protein targets that are specifically activated in disease states — particularly in idiopathic pulmonary fibrosis (IPF), a fatal scarring lung disease, and solid tumor oncology. Endeavor's platform emphasizes structural biology and medicinal chemistry to design compounds with high selectivity for disease-driving targets, minimizing off-target effects that have limited the tolerability of earlier investigational drugs. The company is led by CEO Tomas Kiselak and supported by a scientific advisory board of leading experts in fibrosis and cancer biology.
Business Model & Competitive Advantage
Endeavor Biomedicines raised a landmark $450M Series B in 2024 led by Arch Venture Partners and GV (Google Ventures), with participation from RA Capital Management, Bristol-Myers Squibb, and other prominent life sciences investors. This is one of the largest Series B financings in biotech history, reflecting the high unmet need in fibrosis and the investors' conviction in Endeavor's target selection and drug discovery platform. The company's lead program is an inhibitor of THY1 (also known as CD90) — a cell surface protein implicated in the activation of fibroblasts and cancer-associated stromal cells — which is advancing toward clinical trials in IPF and potentially in solid tumors with fibrotic stroma.
Competitive Landscape 2025–2026
Endeavor Biomedicines competes in the fibrosis drug development space alongside companies like United Therapeutics, Galapagos (partnered with Gilead), Pliant Therapeutics, and Bridge Biotherapeutics. IPF has an FDA-approved standard of care (pirfenidone and nintedanib) that slows disease progression but does not reverse fibrosis or significantly improve survival, representing a clear opportunity for transformative therapies. In oncology, the tumor microenvironment and cancer-associated fibroblasts are increasingly recognized as critical barriers to immunotherapy efficacy, creating a second major opportunity for Endeavor's anti-fibrotic target biology.
Key Differentiators
Emerging Innovator
Endeavor Biomedicines is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Endeavor Biomedicines with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Endeavor Biomedicines? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Endeavor Biomedicines Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Endeavor Biomedicines vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →